Imported malaria is increasing in Western countries, leading to a high
mortality rate among severe cases, mainly due to delayed diagnosis an
d treatment. The authors carried out a 7 years retrospective study (19
89-1995) on 205 patients diagnosed with malaria, in the Department of
Infectious Diseases, in the Lisbon S. Maria Hospital,. The annual rate
was 30 cases per year. Of these patients, 146 (71%) were male, 107 (5
2%) were black, 121 (59%) lived in endemic malaria areas. The origin o
f infection was mainly western Africa, Angola being the country with t
he most cases (47%). Plasmodium falciparum accounted for 93% of the to
tal infections, followed by P. vivax (5%), P. malariae (1%) and P. ova
le (0.5%). In 9 patients mixed infections were found (P. falciparum/P.
vivax, 6 cases; P. falciparum/P. malariae, 2 cases; P. malariae/P. vi
vax, 1 case). Only 45 patients (22%) had received malarial prophylaxis
. Thrombopenia was the most frequent biological sign (present in 70% o
f the cases), followed to a lesser degree by LDH elevation, anemia, an
d liver dysfunction. Nineteen patients (9%) developed severe malaria c
omplications (10 cerebral malaria, 10 renal failure, 2 pulmonary distr
ess, and 2 splenic infarcts). Severe malaria was more frequent in whit
e patients and in those living outside endemic areas. Prior chemoproph
ylaxis was equally frequent between both groups. Six patients died, th
e risk of dead being higher among those with multiple organ failure.